Correction: Are Glucagon-Like Peptide‑1 (GLP-1) Receptor Agonists Central Nervous System (CNS) Penetrant: A Narrative Review
Neurology and Therapy · 2025-08 · 14 (4) · 1167-1168
DOI: 10.1007/s40120-025-00758-2 ↗Kurz gefasst
Korrektur in der Zeitschrift Neurology and Therapy, online erschienen am 25.06.2025. Verfasst von Juliana West und 7 weiteren Autor:innen. Beteiligte Einrichtung: Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Brain and Cognition Discovery Foundation, 77 Bloor Street West, Suite 617, Toronto, ON, M5S 1M2, Canada.
- Department of Pharmacology and Toxicology, University of Toronto, Toronto, ON, Canada.
- Institute of Medical Science, University of Toronto, Toronto, ON, Canada.
- Mood Disorder Psychopharmacology Unit, University Health Network, Toronto, ON, Canada.
- Department of Psychiatry, University of Toronto, Toronto, Canada. roger.mcintyre@bcdf.org.
Zitieren
APA
West, J., Li, M., Wong, S., Le, G. H., Teopiz, K. M., Valentino, K., Dri, C. E., & McIntyre, R. S. (2025). Correction: Are Glucagon-Like Peptide‑1 (GLP-1) Receptor Agonists Central Nervous System (CNS) Penetrant: A Narrative Review. Neurology and Therapy, 14(4), 1167-1168. https://doi.org/10.1007/s40120-025-00758-2
Vancouver
West J, Li M, Wong S, Le GH, Teopiz KM, Valentino K, et al. Correction: Are Glucagon-Like Peptide‑1 (GLP-1) Receptor Agonists Central Nervous System (CNS) Penetrant: A Narrative Review. Neurology and Therapy. 2025;14(4):1167-1168. doi:10.1007/s40120-025-00758-2
BibTeX
@article{West2025,
author = {West, Juliana and Li, Maggie and Wong, Sabrina and Le, Gia Han and Teopiz, Kayla M and Valentino, Kyle and Dri, Christine E and McIntyre, Roger S},
title = {Correction: Are Glucagon-Like Peptide‑1 (GLP-1) Receptor Agonists Central Nervous System (CNS) Penetrant: A Narrative Review},
journal = {Neurology and Therapy},
year = {2025},
volume = {14},
number = {4},
pages = {1167--1168},
doi = {10.1007/s40120-025-00758-2}
}
EUVIMED